epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Strattera

atomoxetine

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Suicidality

incr. risk of suicidality in children/adolescents with ADHD, especially during 1st months of tx; weigh risk vs. benefit; co-morbidities occurring with ADHD may be associated with incr. risk of suicidal ideation or behavior; observe closely for clinical worsening, suicidality, or unusual behavior changes; not approved for major depression; avg risk 0.4% with atomoxetine vs. none with placebo in pooled analyses of short-term use, no suicides in these trials

Adult Dosing .

Dosage forms:  CAP: 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg

ADHD

[80 mg/day PO divided qd-bid]
Start: 40 mg PO qam for at least 3 days; Max: 100 mg/day; Info: may incr. to 100 mg/day after 2-4wk; in CYP2D6 poor metabolizers, start 40 mg PO qam x4wk; do not open cap; periodically reassess need for tx

cataplexy (off-label)

[40-100 mg/day PO divided qd-bid]
Start: 20 mg PO qam for at least 3 days; Max: 100 mg/day; Info: may incr. to 100 mg/day after 2-4wk; in CYP2D6 poor metabolizers, start 20 mg PO qam x4wk; do not open cap

renal dosing

[see below]
renal impairment: no adjustment
HD/PD: not defined

hepatic dosing

[adjust dose amount]
Child-Pugh Class B: decr. usual start and target dose by 50%; Child-Pugh Class C: decr. usual start and target dose by 75%

Peds Dosing .

Dosage forms:  CAP: 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg

ADHD

[6 yo and older, <70 kg]
Dose: 1.2 mg/kg/day PO divided qd-bid; Start: 0.5 mg/kg/dose PO qam for at least 3 days; Max: 1.4 mg/kg/day; Info: in CYP2D6 poor metabolizers, start 0.5 mg/kg/dose PO qam x4wk; do not open cap; periodically reassess need for tx
[6 yo and older, >70 kg]
Dose: 80 mg/day PO divided qd-bid; Start: 40 mg PO qam for at least 3 days; Max: 100 mg/day; Info: may incr. to 100 mg/day after 2-4wk; in CYP2D6 poor metabolizers, start 40 mg PO qam x4wk; do not open cap; periodically reassess need for tx

cataplexy (off-label)

[5 yo and older]
Dose: 10-25 mg PO qd; Start: 10 mg PO qam for at least 3 days; Max: 100 mg/day; Info: may incr. to 100 mg/day after 2-4wk; in CYP2D6 poor metabolizers, start 10 mg PO qam x4wk; do not open cap

renal dosing

[see below]
renal impairment: no adjustment
HD/PD: not defined

hepatic dosing

[adjust dose amount]
Child-Pugh Class B: decr. usual start and target dose by 50%; Child-Pugh Class C: decr. usual start and target dose by 75%

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@413cab9b
  • hypersensitivity to drug or ingredient
  • MAO inhibitor use within 14 days
  • glaucoma, angle-closure
  • pheochromocytoma
  • pheochromocytoma history
  • cardiac abnormality, structural
  • cardiomyopathy
  • arrhythmia, severe
  • cardiovascular disease, severe
  • cerebrovascular disease, severe
  • caution: peds patients
  • caution: adolescent patients
  • caution: CYP2D6 poor metabolizers
  • caution: hepatic impairment
  • caution: cardiovascular disease
  • caution: cardiovascular disease history
  • caution: tachycardia
  • caution: HTN
  • caution: hypotension
  • caution: cerebrovascular disease
  • caution: depression
  • caution: bipolar disorder
  • caution: bipolar disorder risk
  • caution: suicide risk

Drug Interactions .

Overview

atomoxetine

selective norepinephrine reuptake inhibitor

Interaction Characteristics:
  • CYP2D6 substrate
  • hypertensive effects
  • tachycardia
Other Info
  • add MAO inhibitor to Interaction Check if recent (14 days) use

Contraindicated

  • isocarboxazid
  • Strattera (atomoxetine)
    +
    isocarboxazid
    1 interaction

    Contraindicated

    atomoxetine + isocarboxazid

    contraindicated w/in 14 days of isocarboxazid or atomoxetine use: combo may incr. risk of HTN (including hypertensive crisis), CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects)

  • linezolid
  • Strattera (atomoxetine)
    +
    linezolid
    1 interaction

    Contraindicated

    atomoxetine + linezolid

    contraindicated w/in 14 days of linezolid or atomoxetine use; D/C atomoxetine and monitor closely if emergency use: combo may incr. risk of HTN, CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects, linezolid reversibly inhibits monoamine oxidase)

  • phenelzine
  • Strattera (atomoxetine)
    +
    phenelzine
    1 interaction

    Contraindicated

    atomoxetine + phenelzine

    contraindicated w/in 14 days of phenelzine or atomoxetine use: combo may incr. risk of HTN (including hypertensive crisis), CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects)

  • procarbazine
  • Strattera (atomoxetine)
    +
    procarbazine
    1 interaction

    Contraindicated

    atomoxetine + procarbazine

    contraindicated w/in 14 days of procarbazine or atomoxetine use: combo may incr. risk of HTN, CNS overstimulation, hyperpyrexia, myoclonus, rigidity, autonomic instability, death (additive effects, procarbazine inhibits monoamine oxidase)

  • rasagiline
  • Strattera (atomoxetine)
    +
    rasagiline
    1 interaction

    Contraindicated

    atomoxetine + rasagiline

    contraindicated w/in 14 days of rasagiline or atomoxetine use: combo may incr. risk of HTN (including hypertensive crisis), CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects)

  • safinamide
  • Strattera (atomoxetine)
    +
    safinamide
    1 interaction

    Contraindicated

    atomoxetine + safinamide

    contraindicated w/in 14 days of safinamide or atomoxetine use: combo may incr. risk of HTN (including hypertensive crisis), CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects)

  • selegiline
  • Strattera (atomoxetine)
    +
    selegiline
    1 interaction

    Contraindicated

    atomoxetine + selegiline

    contraindicated w/in 14 days of selegiline or atomoxetine use: combo may incr. risk of HTN, CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects)

  • selegiline transdermal
  • Strattera (atomoxetine)
    +
    selegiline transdermal
    1 interaction

    Contraindicated

    atomoxetine + selegiline transdermal

    contraindicated w/in 14 days of selegiline or atomoxetine use: combo may incr. risk of HTN (including hypertensive crisis), CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects)

  • tranylcypromine
  • Strattera (atomoxetine)
    +
    tranylcypromine
    1 interaction

    Contraindicated

    atomoxetine + tranylcypromine

    contraindicated w/in 14 days of tranylcypromine or atomoxetine use: combo may incr. risk of HTN, CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects)

  • yohimbe
  • Strattera (atomoxetine)
    +
    yohimbe
    1 interaction

    Contraindicated

    atomoxetine + yohimbe

    contraindicated w/in 14 days of yohimbe or atomoxetine use: combo may incr. risk of HTN, tachycardia, CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects, yohimbe inhibits monoamine oxidase)

Avoid/Use Alternative

  • albuterol
  • Strattera (atomoxetine)
    +
    albuterol
    1 interaction

    Avoid/Use Alternative

    atomoxetine + albuterol

    use alternative or monitor BP, HR w/ oral albuterol; risk may be lower w/ inhaled albuterol: combo may incr. risk of HTN, tachycardia (additive effects)

  • dronabinol
  • Strattera (atomoxetine)
    +
    dronabinol
    1 interaction

    Avoid/Use Alternative

    atomoxetine + dronabinol

    avoid combo: combo may incr. risk of HTN, tachycardia (additive effects)

  • ephedra
  • Strattera (atomoxetine)
    +
    ephedra
    1 interaction

    Avoid/Use Alternative

    atomoxetine + ephedra

    avoid combo: combo may incr. risk of HTN, tachycardia (additive effects)

  • epinephrine inhaled
  • Strattera (atomoxetine)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    atomoxetine + epinephrine inhaled

    avoid combo: combo may incr. risk of tachycardia, HTN, including hypertensive crisis (additive effects)

  • furosemide
  • Strattera (atomoxetine)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    atomoxetine + furosemide

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • landiolol
  • Strattera (atomoxetine)
    +
    landiolol
    1 interaction

    Avoid/Use Alternative

    atomoxetine + landiolol

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • midodrine
  • Strattera (atomoxetine)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    atomoxetine + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • viloxazine
  • Strattera (atomoxetine)
    +
    viloxazine
    1 interaction

    Avoid/Use Alternative

    atomoxetine + viloxazine

    avoid combo: combo may incr. risk of HTN, tachycardia, other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

  • abiraterone acetate
  • Strattera (atomoxetine)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    atomoxetine + abiraterone acetate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • acebutolol
  • Strattera (atomoxetine)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + acebutolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • albuterol inhaled
  • Strattera (atomoxetine)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    atomoxetine + albuterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • aliskiren
  • Strattera (atomoxetine)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    atomoxetine + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • almotriptan
  • Strattera (atomoxetine)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + almotriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • amiloride
  • Strattera (atomoxetine)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    atomoxetine + amiloride

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amitriptyline
  • Strattera (atomoxetine)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    atomoxetine + amitriptyline

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • amlodipine
  • Strattera (atomoxetine)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amoxapine
  • Strattera (atomoxetine)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + amoxapine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • amphetamine
  • Strattera (atomoxetine)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + amphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • angiotensin II
  • Strattera (atomoxetine)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    atomoxetine + angiotensin II

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aprocitentan
  • Strattera (atomoxetine)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Strattera (atomoxetine)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    atomoxetine + arformoterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • armodafinil
  • Strattera (atomoxetine)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    atomoxetine + armodafinil

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • asciminib
  • Strattera (atomoxetine)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + asciminib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atenolol
  • Strattera (atomoxetine)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atogepant
  • Strattera (atomoxetine)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    atomoxetine + atogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atropine
  • Strattera (atomoxetine)
    +
    atropine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + atropine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • atropine ophthalmic
  • Strattera (atomoxetine)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    atomoxetine + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • axitinib
  • Strattera (atomoxetine)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + axitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • azilsartan medoxomil
  • Strattera (atomoxetine)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    atomoxetine + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benazepril
  • Strattera (atomoxetine)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • Strattera (atomoxetine)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + benzphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • benztropine
  • Strattera (atomoxetine)
    +
    benztropine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + benztropine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • betamethasone
  • Strattera (atomoxetine)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + betamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betaxolol
  • Strattera (atomoxetine)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • Strattera (atomoxetine)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    atomoxetine + bevacizumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bismuth subsalicylate
  • Strattera (atomoxetine)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    atomoxetine + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • Strattera (atomoxetine)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + bisoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • brigatinib
  • Strattera (atomoxetine)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + brigatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • budesonide
  • Strattera (atomoxetine)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + budesonide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bumetanide
  • Strattera (atomoxetine)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + bumetanide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bupropion
  • Strattera (atomoxetine)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    atomoxetine + bupropion

    monitor BP; maintain atomoxetine start dose x4wk, then incr. to target dose only if inadequate response and well-tolerated: combo may incr. atomoxetine levels, risk of HTN, other adverse effects (hepatic metabolism inhibited, additive effects)

  • cabozantinib
  • Strattera (atomoxetine)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + cabozantinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • caffeine
  • Strattera (atomoxetine)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + caffeine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • caffeine citrate
  • Strattera (atomoxetine)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    atomoxetine + caffeine citrate

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • candesartan cilexetil
  • Strattera (atomoxetine)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    atomoxetine + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabis
  • Strattera (atomoxetine)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    atomoxetine + cannabis

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • captopril
  • Strattera (atomoxetine)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carfilzomib
  • Strattera (atomoxetine)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + carfilzomib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • carvedilol
  • Strattera (atomoxetine)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + carvedilol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • celecoxib
  • Strattera (atomoxetine)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + celecoxib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • chlorothiazide
  • Strattera (atomoxetine)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + chlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • chlorthalidone
  • Strattera (atomoxetine)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + chlorthalidone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clevidipine
  • Strattera (atomoxetine)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clomipramine
  • Strattera (atomoxetine)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + clomipramine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • clonidine
  • Strattera (atomoxetine)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cocaine
  • Strattera (atomoxetine)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + cocaine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • copanlisib
  • Strattera (atomoxetine)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + copanlisib

    monitor BP: combo may incr. risk of HTN (additive effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Strattera (atomoxetine)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + corticotropin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cortisone
  • Strattera (atomoxetine)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + cortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cyclosporine
  • Strattera (atomoxetine)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + cyclosporine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dacomitinib
  • Strattera (atomoxetine)
    +
    dacomitinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + dacomitinib

    maintain atomoxetine start dose x4wk, then incr. to target dose only if inadequate response and well-tolerated: combo may incr. atomoxetine levels, risk of adverse effects (hepatic metabolism inhibited)

  • danazol
  • Strattera (atomoxetine)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + danazol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • darbepoetin alfa
  • Strattera (atomoxetine)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    atomoxetine + darbepoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • deflazacort
  • Strattera (atomoxetine)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    atomoxetine + deflazacort

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desipramine
  • Strattera (atomoxetine)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + desipramine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • desmopressin
  • Strattera (atomoxetine)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + desmopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desvenlafaxine
  • Strattera (atomoxetine)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + desvenlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexamethasone
  • Strattera (atomoxetine)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + dexamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexmethylphenidate
  • Strattera (atomoxetine)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    atomoxetine + dexmethylphenidate

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • dextroamphetamine
  • Strattera (atomoxetine)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + dextroamphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • diclofenac
  • Strattera (atomoxetine)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    atomoxetine + diclofenac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac topical
  • Strattera (atomoxetine)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    atomoxetine + diclofenac topical

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dicyclomine
  • Strattera (atomoxetine)
    +
    dicyclomine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + dicyclomine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • diethylpropion
  • Strattera (atomoxetine)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    atomoxetine + diethylpropion

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • diflunisal
  • Strattera (atomoxetine)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    atomoxetine + diflunisal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dihydroergotamine
  • Strattera (atomoxetine)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + dihydroergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • diltiazem
  • Strattera (atomoxetine)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    atomoxetine + diltiazem

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dobutamine
  • Strattera (atomoxetine)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + dobutamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • dopamine
  • Strattera (atomoxetine)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + dopamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • doxapram
  • Strattera (atomoxetine)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    atomoxetine + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Strattera (atomoxetine)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • doxepin
  • Strattera (atomoxetine)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + doxepin

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • droxidopa
  • Strattera (atomoxetine)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    atomoxetine + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • eletriptan
  • Strattera (atomoxetine)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + eletriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • enalapril
  • Strattera (atomoxetine)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • Strattera (atomoxetine)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    atomoxetine + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine injection
  • Strattera (atomoxetine)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ephedrine injection

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, exaggerated pressor response (additive effects)

  • ephedrine oral
  • Strattera (atomoxetine)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ephedrine oral

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • epinephrine
  • Strattera (atomoxetine)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + epinephrine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • eplerenone
  • Strattera (atomoxetine)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Strattera (atomoxetine)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    atomoxetine + epoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eptinezumab
  • Strattera (atomoxetine)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    atomoxetine + eptinezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • erenumab
  • Strattera (atomoxetine)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    atomoxetine + erenumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ergotamine
  • Strattera (atomoxetine)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • esketamine
  • Strattera (atomoxetine)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • esmolol
  • Strattera (atomoxetine)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Strattera (atomoxetine)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    atomoxetine + estetrol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • estradiol (contraceptive)
  • Strattera (atomoxetine)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    atomoxetine + estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ethacrynic acid
  • Strattera (atomoxetine)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ethacrynic acid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethanol (alcoholic beverage)
  • Strattera (atomoxetine)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of HTN (chronic alcohol use) (additive effects)

  • ethinyl estradiol (contraceptive)
  • Strattera (atomoxetine)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ethinyl estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etodolac
  • Strattera (atomoxetine)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    atomoxetine + etodolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etrasimod
  • Strattera (atomoxetine)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    atomoxetine + etrasimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • felodipine
  • Strattera (atomoxetine)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Strattera (atomoxetine)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fenfluramine

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • fenoldopam
  • Strattera (atomoxetine)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Strattera (atomoxetine)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fenoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fingolimod
  • Strattera (atomoxetine)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fingolimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fludrocortisone
  • Strattera (atomoxetine)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fludrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fluoxetine
  • Strattera (atomoxetine)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fluoxetine

    maintain atomoxetine start dose x4wk, then incr. to target dose only if inadequate response and well-tolerated: combo may incr. atomoxetine levels, risk of adverse effects (hepatic metabolism inhibited)

  • flurbiprofen
  • Strattera (atomoxetine)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    atomoxetine + flurbiprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • formoterol inhaled
  • Strattera (atomoxetine)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    atomoxetine + formoterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • fosinopril
  • Strattera (atomoxetine)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fostamatinib
  • Strattera (atomoxetine)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fremanezumab
  • Strattera (atomoxetine)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fremanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • Strattera (atomoxetine)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + frovatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • Strattera (atomoxetine)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + fruquintinib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • galcanezumab
  • Strattera (atomoxetine)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    atomoxetine + galcanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • glycopyrrolate
  • Strattera (atomoxetine)
    +
    glycopyrrolate
    1 interaction

    Monitor/Modify Tx

    atomoxetine + glycopyrrolate

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • guanfacine
  • Strattera (atomoxetine)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + guanfacine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hoodia
  • Strattera (atomoxetine)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    atomoxetine + hoodia

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • hydralazine
  • Strattera (atomoxetine)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Strattera (atomoxetine)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + hydrochlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrocortisone
  • Strattera (atomoxetine)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + hydrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydroxocobalamin IV
  • Strattera (atomoxetine)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    atomoxetine + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hyoscyamine
  • Strattera (atomoxetine)
    +
    hyoscyamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + hyoscyamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ibrutinib
  • Strattera (atomoxetine)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ibrutinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibuprofen
  • Strattera (atomoxetine)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ibuprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • imipramine
  • Strattera (atomoxetine)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + imipramine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • indapamide
  • Strattera (atomoxetine)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + indapamide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • indomethacin
  • Strattera (atomoxetine)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + indomethacin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • irbesartan
  • Strattera (atomoxetine)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isoproterenol
  • Strattera (atomoxetine)
    +
    isoproterenol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + isoproterenol

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • isradipine
  • Strattera (atomoxetine)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketamine
  • Strattera (atomoxetine)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ketamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other sympathomimetic adverse effects (additive effects)

  • ketoprofen
  • Strattera (atomoxetine)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ketoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac
  • Strattera (atomoxetine)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ketorolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • labetalol
  • Strattera (atomoxetine)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • Strattera (atomoxetine)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • leflunomide
  • Strattera (atomoxetine)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + leflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lenvatinib
  • Strattera (atomoxetine)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + lenvatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levalbuterol inhaled
  • Strattera (atomoxetine)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    atomoxetine + levalbuterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • levomilnacipran
  • Strattera (atomoxetine)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    atomoxetine + levomilnacipran

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • levothyroxine
  • Strattera (atomoxetine)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + levothyroxine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • licorice
  • Strattera (atomoxetine)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    atomoxetine + licorice

    monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects)

  • lifileucel
  • Strattera (atomoxetine)
    +
    lifileucel
    1 interaction

    Monitor/Modify Tx

    atomoxetine + lifileucel

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • liothyronine
  • Strattera (atomoxetine)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + liothyronine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • liraglutide
  • Strattera (atomoxetine)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + liraglutide

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • lisdexamfetamine
  • Strattera (atomoxetine)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + lisdexamfetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • lisinopril
  • Strattera (atomoxetine)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lorlatinib
  • Strattera (atomoxetine)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + lorlatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • losartan
  • Strattera (atomoxetine)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumacaftor/ivacaftor
  • Strattera (atomoxetine)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    atomoxetine + lumacaftor/ ivacaftor

    monitor BP: combo may incr. risk of HTN (additive effects)

  • luspatercept
  • Strattera (atomoxetine)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    atomoxetine + luspatercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • magnesium salicylate
  • Strattera (atomoxetine)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    atomoxetine + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may incr. risk of HTN (additive effects)

  • mavorixafor
  • Strattera (atomoxetine)
    +
    mavorixafor
    1 interaction

    Monitor/Modify Tx

    atomoxetine + mavorixafor

    maintain atomoxetine start dose x4wk, then incr. to target dose only if inadequate response and well-tolerated: combo may incr. atomoxetine levels, risk of adverse effects (hepatic metabolism inhibited)

  • meclofenamate
  • Strattera (atomoxetine)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    atomoxetine + meclofenamate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mefenamic acid
  • Strattera (atomoxetine)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    atomoxetine + mefenamic acid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meloxicam
  • Strattera (atomoxetine)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    atomoxetine + meloxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methamphetamine
  • Strattera (atomoxetine)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + methamphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Strattera (atomoxetine)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    atomoxetine + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methscopolamine
  • Strattera (atomoxetine)
    +
    methscopolamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + methscopolamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • methyldopa
  • Strattera (atomoxetine)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    atomoxetine + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylergonovine
  • Strattera (atomoxetine)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + methylergonovine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • methylprednisolone
  • Strattera (atomoxetine)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + methylprednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyltestosterone
  • Strattera (atomoxetine)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + methyltestosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metoclopramide
  • Strattera (atomoxetine)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + metoclopramide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • Strattera (atomoxetine)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + metolazone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoprolol
  • Strattera (atomoxetine)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • milnacipran
  • Strattera (atomoxetine)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    atomoxetine + milnacipran

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • minoxidil
  • Strattera (atomoxetine)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    atomoxetine + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Strattera (atomoxetine)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    atomoxetine + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • modafinil
  • Strattera (atomoxetine)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    atomoxetine + modafinil

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • moexipril
  • Strattera (atomoxetine)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nabumetone
  • Strattera (atomoxetine)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + nabumetone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nadolol
  • Strattera (atomoxetine)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Strattera (atomoxetine)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    atomoxetine + naproxen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naratriptan
  • Strattera (atomoxetine)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + naratriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naxitamab
  • Strattera (atomoxetine)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    atomoxetine + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Strattera (atomoxetine)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nicardipine
  • Strattera (atomoxetine)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nifedipine
  • Strattera (atomoxetine)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nimodipine
  • Strattera (atomoxetine)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • niraparib
  • Strattera (atomoxetine)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nisoldipine
  • Strattera (atomoxetine)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • norepinephrine
  • Strattera (atomoxetine)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + norepinephrine

    monitor BP: combo may incr. risk of severe HTN, exaggerated pressor response (additive effects)

  • nortriptyline
  • Strattera (atomoxetine)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    atomoxetine + nortriptyline

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • obinutuzumab
  • Strattera (atomoxetine)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    atomoxetine + obinutuzumab

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • olmesartan medoxomil
  • Strattera (atomoxetine)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    atomoxetine + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Strattera (atomoxetine)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    atomoxetine + olodaterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • orphenadrine
  • Strattera (atomoxetine)
    +
    orphenadrine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + orphenadrine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • osilodrostat
  • Strattera (atomoxetine)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    atomoxetine + osilodrostat

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxaprozin
  • Strattera (atomoxetine)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + oxaprozin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline nasal
  • Strattera (atomoxetine)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    atomoxetine + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • Strattera (atomoxetine)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • ozanimod
  • Strattera (atomoxetine)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ozanimod

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • paroxetine
  • Strattera (atomoxetine)
    +
    paroxetine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + paroxetine

    maintain atomoxetine start dose x4wk, then incr. to target dose only if inadequate response and well-tolerated: combo may incr. atomoxetine levels, risk of adverse effects (hepatic metabolism inhibited)

  • pazopanib
  • Strattera (atomoxetine)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + pazopanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • perindopril
  • Strattera (atomoxetine)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • Strattera (atomoxetine)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + pexidartinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phendimetrazine
  • Strattera (atomoxetine)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + phendimetrazine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • phenoxybenzamine
  • Strattera (atomoxetine)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + phenoxybenzamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • Strattera (atomoxetine)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + phentermine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • phentolamine
  • Strattera (atomoxetine)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + phentolamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Strattera (atomoxetine)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + phenylephrine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • phenylephrine injection
  • Strattera (atomoxetine)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    atomoxetine + phenylephrine injection

    monitor BP: combo may incr. risk of HTN, exaggerated pressor response (additive effects)

  • phenylephrine nasal
  • Strattera (atomoxetine)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    atomoxetine + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine ophthalmic
  • Strattera (atomoxetine)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    atomoxetine + phenylephrine ophthalmic

    monitor BP, HR; risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN, tachycardia (additive effects)

  • phenylephrine rectal
  • Strattera (atomoxetine)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    atomoxetine + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pindolol
  • Strattera (atomoxetine)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • piroxicam
  • Strattera (atomoxetine)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    atomoxetine + piroxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponatinib
  • Strattera (atomoxetine)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ponatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponesimod
  • Strattera (atomoxetine)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ponesimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pralsetinib
  • Strattera (atomoxetine)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + pralsetinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prazosin
  • Strattera (atomoxetine)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisolone
  • Strattera (atomoxetine)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + prednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prednisone
  • Strattera (atomoxetine)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + prednisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • propranolol
  • Strattera (atomoxetine)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • protriptyline
  • Strattera (atomoxetine)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    atomoxetine + protriptyline

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • pseudoephedrine
  • Strattera (atomoxetine)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + pseudoephedrine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • quetiapine
  • Strattera (atomoxetine)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + quetiapine

    monitor BP, especially in pts <18 yo: combo may incr. risk of HTN (additive effects)

  • quinapril
  • Strattera (atomoxetine)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • quinidine (antiarrhythmic)
  • Strattera (atomoxetine)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    atomoxetine + quinidine (antiarrhythmic)

    maintain atomoxetine start dose x4wk, then incr. to target dose only if inadequate response and well-tolerated: combo may incr. atomoxetine levels, risk of adverse effects (hepatic metabolism inhibited)

  • quinidine (CYP2D6 inhibitor)
  • Strattera (atomoxetine)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Monitor/Modify Tx

    atomoxetine + quinidine (CYP2D6 inhibitor)

    maintain atomoxetine start dose x4wk, then incr. to target dose only if inadequate response and well-tolerated: combo may incr. atomoxetine levels, risk of adverse effects (hepatic metabolism inhibited)

  • ramipril
  • Strattera (atomoxetine)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramucirumab
  • Strattera (atomoxetine)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ramucirumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • regorafenib
  • Strattera (atomoxetine)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + regorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rimegepant
  • Strattera (atomoxetine)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    atomoxetine + rimegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • Strattera (atomoxetine)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rizatriptan
  • Strattera (atomoxetine)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + rizatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ropinirole
  • Strattera (atomoxetine)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rotigotine transdermal
  • Strattera (atomoxetine)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    atomoxetine + rotigotine transdermal

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • salmeterol inhaled
  • Strattera (atomoxetine)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    atomoxetine + salmeterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • salsalate
  • Strattera (atomoxetine)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    atomoxetine + salsalate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • selpercatinib
  • Strattera (atomoxetine)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + selpercatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • siponimod
  • Strattera (atomoxetine)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    atomoxetine + siponimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • solriamfetol
  • Strattera (atomoxetine)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + solriamfetol

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • sorafenib
  • Strattera (atomoxetine)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + sorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • spironolactone
  • Strattera (atomoxetine)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + spironolactone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sulindac
  • Strattera (atomoxetine)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    atomoxetine + sulindac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sumatriptan
  • Strattera (atomoxetine)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + sumatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • Strattera (atomoxetine)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + sunitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tacrolimus
  • Strattera (atomoxetine)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    atomoxetine + tacrolimus

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tagraxofusp
  • Strattera (atomoxetine)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    atomoxetine + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • telmisartan
  • Strattera (atomoxetine)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terazosin
  • Strattera (atomoxetine)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbinafine
  • Strattera (atomoxetine)
    +
    terbinafine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + terbinafine

    maintain atomoxetine start dose x4wk, then incr. to target dose only if inadequate response and well-tolerated: combo may incr. atomoxetine levels, risk of adverse effects (hepatic metabolism inhibited)

  • terbutaline
  • Strattera (atomoxetine)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    atomoxetine + terbutaline

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • teriflunomide
  • Strattera (atomoxetine)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + teriflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • testosterone
  • Strattera (atomoxetine)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + testosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • thyroid
  • Strattera (atomoxetine)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    atomoxetine + thyroid

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • timolol
  • Strattera (atomoxetine)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    atomoxetine + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tivozanib
  • Strattera (atomoxetine)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + tivozanib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tolmetin
  • Strattera (atomoxetine)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + tolmetin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • torsemide
  • Strattera (atomoxetine)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    atomoxetine + torsemide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trametinib
  • Strattera (atomoxetine)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + trametinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trandolapril
  • Strattera (atomoxetine)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    atomoxetine + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • triamcinolone
  • Strattera (atomoxetine)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + triamcinolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • triamterene
  • Strattera (atomoxetine)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    atomoxetine + triamterene

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trimipramine
  • Strattera (atomoxetine)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + trimipramine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • trospium
  • Strattera (atomoxetine)
    +
    trospium
    1 interaction

    Monitor/Modify Tx

    atomoxetine + trospium

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ubrogepant
  • Strattera (atomoxetine)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ubrogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vadadustat
  • Strattera (atomoxetine)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    atomoxetine + vadadustat

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • valsartan
  • Strattera (atomoxetine)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vamorolone
  • Strattera (atomoxetine)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    atomoxetine + vamorolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vandetanib
  • Strattera (atomoxetine)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    atomoxetine + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vasopressin
  • Strattera (atomoxetine)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • venlafaxine
  • Strattera (atomoxetine)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    atomoxetine + venlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • Strattera (atomoxetine)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    atomoxetine + verapamil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vilanterol inhaled
  • Strattera (atomoxetine)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    atomoxetine + vilanterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • voclosporin
  • Strattera (atomoxetine)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    atomoxetine + voclosporin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zavegepant
  • Strattera (atomoxetine)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    atomoxetine + zavegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Strattera (atomoxetine)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    atomoxetine + ziv-aflibercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zolmitriptan
  • Strattera (atomoxetine)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    atomoxetine + zolmitriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@5e0c6429
  • psychosis
  • mania
  • aggressive behavior
  • suicidal ideation
  • depression
  • hypotension, orthostatic
  • syncope
  • HTN
  • tachycardia
  • QT prolongation
  • MI
  • stroke
  • sudden death
  • seizures
  • hepatotoxicity
  • priapism
  • Raynaud phenomenon
  • hypersensitivity reaction
  • angioedema
  • anaphylaxis
  • rhabdomyolysis

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@7917dafa
  • xerostomia
  • headache
  • abdominal pain
  • anorexia
  • nausea
  • vomiting
  • insomnia
  • somnolence
  • erectile dysfunction
  • hot flashes
  • fatigue
  • urinary hesitancy
  • urinary retention
  • irritability
  • dysmenorrhea
  • dizziness
  • constipation
  • dyspepsia
  • libido decr.
  • diaphoresis
  • weight loss
  • palpitations
  • sleep disorders
  • ejaculatory dysfunction
  • dysuria
  • paresthesia
  • rigors
  • BP incr.
  • HR incr.
  • rash
  • mood swings
  • tremor

Safety/Monitoring .

Monitoring Parameters
cardiac evaluation at baseline; BP, HR at baseline, after dose incr, then periodically; height, weight in peds at baseline, then periodically; symptoms of suicidality, clinical worsening, and/or unusual behavior changes in peds, especially during initial tx or after dose changes

Look/Sound-Alike Drug Names
atomoxetine confused with: atorvastatin

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy, especially in CYP2D6 poor metabolizers; risk of teratogenicity not expected based on limited human data; no known risk of fetal harm based on animal data at 7x and 17x MRHD

Pregnancy Registry

enroll patients or encourage patients to enroll in National Pregnancy Registry for ADHD Medications at 1-866-961-2388 or https://womensmentalhealth.org/adhd-medications

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@245465c6

Metabolism: for atomoxetine: liver; CYP450: 2C19, 2D6 substrate; Info: minor active metabolites

Excretion: for atomoxetine: urine primarily, feces; Half-life: 5.2h, 21.6h (poor metabolizers at CYP2D6)

Subclass: Attention Deficit Hyperactivity Disorder (ADHD) ; Narcolepsy/Somnolence

Mechanism of Action
for atomoxetine: exact mechanism of action unknown; selectively inhibits norepinephrine reuptake

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Eli Lilly and Co.

com.epocrates.rxweb.beans.DrugOtherInfoBean@737fe4fa

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral capsule:

  • 10 mg (30 ea): $413.00
  • 18 mg (30 ea): $413.00
  • 25 mg (30 ea): $413.00
  • 40 mg (30 ea): $448.00
  • 60 mg (30 ea): $448.00
  • 80 mg (30 ea): $482.00
  • 100 mg (30 ea): $482.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information